Literature DB >> 10599034

Beneficial effect of piracetam monotherapy on post-ischaemic palatal myoclonus.

D Karacostas1, T Doskas, N Artemis, K Vadicolias, I Milonas.   

Abstract

A 70-year-old hypertensive woman suffered a subarachnoid haemorrhage followed by delayed vasospasm in the basal cerebral arteries. This resulted in multiple ischaemic lesions in the right middle cerebral artery region and contralateral post-ischaemic palatal myoclonus. In this setting, piracetam administered in high doses (24-36 g/day), abolished the myoclonus observed in this patient. Although there is evidence from case reports and clinical trials of the therapeutic efficacy of piracetam in patients with skeletal myoclonus of various causes, to our knowledge this is the first report indicating the beneficial effect of piracetam monotherapy on post-ischaemic palatal myoclonus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599034     DOI: 10.1177/030006059902700408

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

1.  Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.

Authors:  Pankaj Paliwal; Debabrata Dash; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.

Authors:  Zhi He; Yun Liao; Min Zheng; Fan-Dian Zeng; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

3.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

4.  Palato-pharyngo-laryngeal myoclonus with recurrent retrograde feeding tube migration after cerebellar hemorrhagic stroke: a case report and review of hypertrophic olivary degeneration.

Authors:  Jamie L Fleet; Ronelle Calver; Gihan C Perera; Zhihui Deng
Journal:  BMC Neurol       Date:  2020-06-03       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.